MSP-2019

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameMSP-2019
Drug Alias Name5-HT2a receptor agonist (Mindset pharma)Psilocybin prodrug (Mindset Pharma)MSP-2019
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMindset Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMindset Pharma Inc
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A